First North Announcement no. 7 2007/ 7th May, 2007 Copenhagen, 7th May, 2007 Summary: The Danish Working Environment Authority has today approved Aresa's application for testing of genetically modified Thale cress. Aresa receives GMO approval. On March 30th 2006 Aresa applied to the Danish Environmental Agency (Skov- og Naturstyrelsen) for release of genetically modified Thale cress. The Thale cress plant is to be used for detection of explosives in soil, e.g. landmines. The Environmental Agency and The Danish Working Environment Authority has evaluated and approved Aresa's GMO application in accordance with the ministry's executive order No. 642 of 28th june 2001 concerning gene-technology and working environment. The testing will take place at an enclosed test site in Jægerspris, Denmark and will be initiated within the coming weeks and will continue throughout the growing season 2007. In order to obtain most possible test data, Aresa will test several genetic variations combined with various eco-types of Thale cress (Arabidopsis thaliana). “This approval is another significant milestone in Aresas continued development of the landmine detecting plant RedDetect™ and is another step towards our aim of becoming a sustainable Plant Biotechnological company over the coming years” states CEO Jarne Elleholm. The content of this message is not expected to have impact on the result for the current financial year. Best regards, Jarne Elleholm CEO Aresa A/S Further information can be obtained by contacting Jarne Elleholm, CEO for Aresa A/S on +45 70227747, mobile: +45 41190136 or to the company's financial advisor HSH Gudme Corporate Finance A/S, Morten Kjærulff, Director, +45 33449431. About Aresa Aresa is a plant biotech company established in 2001 by the company's current CSO, Carsten Meier and has origins from the Institute of Molecular Biology at Copenhagen University. Aresa has developed two plant based technology platforms, BioSensor for the detection of substances in soil, hereunder evaporation of explosives from landmines; and BioPharma, a tool for the optimisation and production of antibodies and proteins in plants. Aresa was listed on the Copenhagen OMX-First North market place in 2006. Aresa is based at Symbion Science Park in Copenhagen and has greenhouse facilities in the outskirts of Copenhagen and test areas in Denmark, Croatia and in Bosnia Herzegovina. Aresa has 16 employees, hereof 8 within research and development and 5 within landmine operations.